-transparent.png){kind=logo}
Refractory response to dopamine (DA) agonists is a common problem in the treatment of Parkinson's disease. In rats with unilateral lesions of the substantia nigra, denervation induced significant increases in striatal 3(H)-spiperone binding sites ipsilateral to the lesion. Chronic treatment with levodopa or with pergolide mesylate significantly decreased the number of 3(H)-spiperone striatal binding sites. Agonist-induced decreases were approximately equivalent in intact and denervated striata and did not appear to be affected by lesions. These results suggest that the poor response to DA agonist in certain parkinsonian patients with chronic drug exposure may be mediated by drug-induced DA receptor down-regulation.
A Reches, and
H R Wagner, and
V Jackson-Lewis, and
E Yablonskaya-Alter, and
S Fahn
January 1987,
Alcohol and drug research,
A Reches, and
H R Wagner, and
V Jackson-Lewis, and
E Yablonskaya-Alter, and
S Fahn
January 2001,
Neuroscience,
A Reches, and
H R Wagner, and
V Jackson-Lewis, and
E Yablonskaya-Alter, and
S Fahn
January 1999,
Brain research,
A Reches, and
H R Wagner, and
V Jackson-Lewis, and
E Yablonskaya-Alter, and
S Fahn
January 2005,
Clinical neuropharmacology,
A Reches, and
H R Wagner, and
V Jackson-Lewis, and
E Yablonskaya-Alter, and
S Fahn
September 1987,
Brain research,
A Reches, and
H R Wagner, and
V Jackson-Lewis, and
E Yablonskaya-Alter, and
S Fahn
May 1987,
Neuropharmacology,
A Reches, and
H R Wagner, and
V Jackson-Lewis, and
E Yablonskaya-Alter, and
S Fahn
January 1997,
Journal of neural transmission (Vienna, Austria : 1996),
A Reches, and
H R Wagner, and
V Jackson-Lewis, and
E Yablonskaya-Alter, and
S Fahn
January 1989,
Neuroscience letters,
A Reches, and
H R Wagner, and
V Jackson-Lewis, and
E Yablonskaya-Alter, and
S Fahn
November 1985,
The American journal of psychiatry,
A Reches, and
H R Wagner, and
V Jackson-Lewis, and
E Yablonskaya-Alter, and
S Fahn
August 1985,
Zhonghua shen jing jing shen ke za zhi = Chinese journal of neurology and psychiatry,
